Urinary sodium is a potent correlate of proteinuria: Lessons from the chronic renal insufficiency cohort study

American Journal of Nephrology

Volumn 36, Issue 5, 2012, Pages 397-404

  Weir, Matthew R ^a   Townsend, Raymond R ^b   Fink, Jeffrey C ^a   Teal, Valerie ^b   Sozio, Stephen M ^c   Anderson, Cheryl A ^c   Appel, Lawrence J ^c   Turban, Sharon ^c   Chen, Jing ^d   He, Jiang ^d   Litbarg, Natasha ^e   Ojo, Akinlolu ^f   Rahman, Mahboob ^g   Rosen, Leigh ^b   Steigerwalt, Susan ^h   Strauss, Louise ^g   Joffe, Marshall M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h St Claire Hospital   (United States)

Author keywords

Blood pressure; Potassium; Proteinuria; Sodium

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; POTASSIUM; PROTEIN; SODIUM;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; POTASSIUM EXCRETION; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; WAIST CIRCUMFERENCE;

FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; SODIUM;

EID: 84867480706     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000342966     Document Type: Article

References (26)

1. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al: Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590-599.
2. Graudal NA, Galloe AM, Garred P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998; 279: 1383-1391.
3. Midgley JP, Matthew AG, Greenwood CM, Logan AG: Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275: 1590-1597.
4. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM: Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med 2010; 152: 481-483.
5. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, et al: Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011; 305: 1777-1785.
6. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Efficacy and variability of the an-tiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989; 36:272-279.
7. Vogt L, Waanders F, Boomsma F, de ZD, Navis G: Effects of dietary sodium and hydro-chlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008; 19: 999-1007.
8. Messerli FH, Schmieder RE, Weir MR: Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med 1997; 157:2449-2452.
9. Tobian L, Hanlon S: High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension 1990; 15:900-903.
10. Weir MR, Dengel DR, Behrens MT, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25: 1339-1344.
11. Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GL, et al: An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 2006; 26: 268-275.
12. Perry IJ, Beevers DG: Salt intake and stroke: a possible direct effect. J Hum Hypertens 1992; 6: 23-25.
13. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, et al: The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 2003; 14(7 suppl 2):S148-S153.
14. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762.
15. D'Elia L, Barba G, Cappuccio FP, Strazzullo P: Potassium intake, stroke, and cardiovascular disease: a meta-analysis of prospective studies. J Am Col l Cardiol 2011; 57: 1210-1219.
16. Astor BC, Matsushita K, Gansevoort RT, van d, V, Woodward M, Levey AS, et al: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340.
17. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al: Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65:2309-2320.
18. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, et al: Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001; 60:1131-1140.
19. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al: Albumin-uria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110:921-927.
20. Myrvang H: Progression of renal disease: high salt intake blunts the benefit of ACE inhibitors and accelerates renal function decline. Nat Rev Nephrol 2012; 8:61.
21. Vegter S, Perna A, Postma MJ, Navis G, Re-muzzi G, Ruggenenti P: Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 2012; 23: 165-173.
22. Yu W, Luying S, Haiyan W, Xiaomei L: Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center. Int Urol Nephrol 2012; 44: 549-556.
23. Nakamura T, Kataoka K, Tokutomi Y, Nako H, Toyama K, Dong YF, et al: Novel mechanism of salt-induced glomerular injury: critical role of eNOS and angiotensin II. J Hy-pertens 2011; 29:1528-1535.
24. Liu K, Dyer AR, Cooper RS, Stamler R, Stamler J: Can overnight urine replace 24hour urine collection to asses salt intake? Hypertension 1979; 1: 529-536.
25. Krikken JA, Laverman GD, Navis G: Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hyper tens 2009; 18: 531-538.
26. Wright JA, Cavanaugh KL: Dietary sodium in chronic kidney disease: a comprehensive approach. Semin Dial 2010; 23: 415-421.